miltefosine has been researched along with pentoxifylline in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, X; Ding, HF; Lang, L; Liu, G; Sun, SY; Yan, C | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Debastiani, RG; Greggianin, GF; Polli, DA; Ribeiro, JB; Sampaio, RN; Santarem, AA | 1 |
| Elias, VM; Osorio-Arango, K; Pinart, M; Pinzón-Flórez, CE; Reveiz, L; Romero, GA; Rueda, JR; Silveira Maia-Elkhoury, AN; Tweed, JA | 1 |
| Barroso, DH; da Motta, JOC; Freire, GSM; Gomes, CM; Kurisky, PS; Martins, SS; Pereira, LIA; Rodrigues, BC; Sampaio, RNR | 1 |
| Alves, LL; Carvalho, JP; Cota, G; Freire, ML; Silva, SN; Souza, CSA | 1 |
2 review(s) available for miltefosine and pentoxifylline
| Article | Year |
|---|---|
Interventions for American cutaneous and mucocutaneous leishmaniasis.
Topics: Administration, Oral; Adult; Antiprotozoal Agents; Azithromycin; BCG Vaccine; Female; Humans; Hyperthermia, Induced; Immunocompetence; Injections, Intramuscular; Injections, Intravenous; Interferon-gamma; Leishmaniasis Vaccines; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine Antimoniate; Pentoxifylline; Phosphorylcholine; Randomized Controlled Trials as Topic | 2020 |
The cure rate after different treatments for mucosal leishmaniasis in the Americas: A systematic review.
Topics: Antimony; Humans; Leishmaniasis, Mucocutaneous; Pentoxifylline | 2022 |
1 trial(s) available for miltefosine and pentoxifylline
| Article | Year |
|---|---|
A Pilot Randomized Clinical Trial: Oral Miltefosine and Pentavalent Antimonials Associated With Pentoxifylline for the Treatment of American Tegumentary Leishmaniasis.
Topics: Antiprotozoal Agents; Humans; Leishmaniasis, Cutaneous; Pentoxifylline; Phosphorylcholine; Pilot Projects; Treatment Outcome; United States | 2021 |
4 other study(ies) available for miltefosine and pentoxifylline
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
Topics: CRISPR-Cas Systems; Gene Targeting; Genes; Genes, Reporter; Genetic Engineering; Humans; Internal Ribosome Entry Sites; Transcription, Genetic | 2015 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Effectiveness of miltefosine-pentoxifylline compared to miltefosine in the treatment of cutaneous leishmaniasis in C57Bl/6 mice.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Leishmaniasis, Cutaneous; Mice, Inbred C57BL; Pentoxifylline; Phosphorylcholine; Time Factors | 2014 |